User profiles for J. A. Williams

John A. Williams

- Verified email at umich.edu - Cited by 24574

Julie A. Williams

- Verified email at pennmedicine.upenn.edu - Cited by 3842

[37] Carbonyl assays for determination of oxidatively modified proteins

RL Levine, JA Williams, EP Stadtman, E Shacter - Methods in enzymology, 1994 - Elsevier
Publisher Summary Enzymes and structural proteins may be attacked whenever free radicals
are generated. As a consequence, oxidative modification of proteins may occur in a variety …

Non-radiative deactivation of the excited states of europium, terbium and ytterbium complexes by proximate energy-matched OH, NH and CH oscillators: an improved …

…, L Royle, AS De Sousa, JAG Williams… - Journal of the …, 1999 - pubs.rsc.org
The radiative rate constants for depopulation of the excited states of closely-related series of
anionic, neutral and cationic europium, terbium and ytterbium complexes have been …

[BOOK][B] Engineering tribology

JA Williams - 2005 - books.google.com
… University and I am grateful to colleagues on the teaching staff for their advice and
comments in its preparation: in particular I should like to thank Professor KL Johnson and Dr JA

[HTML][HTML] PD-L1 immunohistochemistry assays for lung cancer: results from phase 1 of the blueprint PD-L1 IHC assay comparison project

…, K Emancipator, I McCaffery, JA Williams… - Journal of Thoracic …, 2017 - Elsevier
Introduction The Blueprint Programmed Death Ligand 1 (PD-L1) Immunohistochemistry (IHC)
Assay Comparison Project is an industrial-academic collaborative partnership to provide …

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

…, R Cozens, MR Jensen, NK Pryer, JA Williams… - Nature medicine, 2015 - nature.com
Profiling candidate therapeutics with limited cancer models during preclinical development
hinders predictions of clinical efficacy and identifying factors that underlie heterogeneous …

Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios

JA Williams, R Hyland, BC Jones, DA Smith… - Drug Metabolism and …, 2004 - ASPET
Glucuronidation is a listed clearance mechanism for 1 in 10 of the top 200 prescribed drugs.
The objective of this article is to encourage those studying ligand interactions with UDP-…

Positron Emission Tomography Reveals Elevated D2 Dopamine Receptors in Drug-Naive Schizophrenics

…, AA Wilson, JKT Toung, J Malat, JA Williams… - Science, 1986 - science.org
In postmortem studies of patients with schizophrenia, D 2 dopamine receptors in the basal
ganglia have been observed to be more numerous than in patients with no history of …

[PDF][PDF] Rest in Drosophila is a sleep-like state

…, SM Finn, KA Panckeri, J Chavkin, JA Williams… - Neuron, 2000 - cell.com
To facilitate the genetic study of sleep, we documented that rest behavior in Drosophila
melanogaster is a sleep-like state. The animals choose a preferred location, become immobile …

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.

…, MS Rosen, RA Taplitz, JA Williams - The Journal of …, 1985 - Am Soc Clin Investig
A sensitive and specific bioassay for the measurement of cholecystokinin (CCK) in human
plasma was developed to determine the molecular forms of CCK in circulation, CCK …

Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity.

MT Makler, JM Ries, JA Williams… - The American journal …, 1993 - europepmc.org
This report compares the use of the lactate dehydrogenase (pLDH) assay with 3H-hypoxanthine
incorporation and Giemsa microscopy for the evaluation of anti-malaria drug inhibition …